Tumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through...

Area of Science:

• Immunology
• Cancer Biology
• Cellular Mechanisms

Background:

• Tumor immune evasion often involves defects in T cell receptor (TCR) signaling.
• Mechanisms by which tumors suppress T cell function are not fully understood.

Purpose of the Study:

• To investigate how tumor microenvironments induce T cell dysfunction.
• To identify factors responsible for tumor-induced T cell suppression.

Main Methods:

• Incubation of human monocytes with tumor cell line supernatants to generate dendritic cells (DCs).
• Co-culture of generated DCs with autologous T cells to assess T cell responses.
• Analysis of CD3/TCR complex expression, T cell apoptosis, and cytokine production.
• Inhibition studies using blocking agents for various enzymes and signaling pathways (NADPH oxidase, arginase, iNOS, IDO, IFN-gamma).
• Identification of tumor-derived factors using biochemical assays.

Main Results:

• Tumor cell supernatants induced monocytes to differentiate into tolerogenic semimature dendritic cells (TDCs).
• TDCs triggered rapid down-regulation of CD3epsilon and TCR-alpha/beta on T cells, leading to T cell apoptosis.
• Accumulation of immunosuppressive DCs and T cell deletion were observed in human tumor tissues.
• TDC-induced T cell impairment was mediated by factors released after DC-lymphocyte interaction.
• NADPH oxidase inhibition significantly reduced the TDC-induced T cell effects.
• Hyaluronan fragments from tumor cells were identified as a key factor inducing TDC formation.

Conclusions:

• Tumor microenvironments educate DCs to a semimature phenotype, contributing to immune evasion.
• Hyaluronan fragments are crucial tumor-derived factors that induce tolerogenic DCs.
• TDCs impair T cell function via CD3/TCR complex defects and apoptosis, mediated partly by NADPH oxidase.